期刊文献+

COMT Val158Met基因多态性与精神分裂症发病风险的Meta分析 被引量:1

COMT Val158Met Gene Polymorphisms and Schizophrenia Susceptibility: A Meta Analysis
下载PDF
导出
摘要 目的:探讨COMTVal158Met基因多态性与精神分裂症患病风险的相关性。方法:在PubMed、CNKI、CBM、EMBASE、MEDLINE和万方数据库中用计算机检索相关文献,运用Meta分析方法对纳入文献进行综合定量及亚组分析。计算合并相对比值比(OR)和95%可信区间(95%CI),使用Review Manager 5.1软件进行分析。结果:入选文献17篇,包括病例组4935例和对照组4282例。COMTVal158Met基因多态性与精神分裂症并无相关性(杂合子比较,P=0.07,I2=1%;隐形遗传模式比较,P=0.11,I2=0%)。亚组分析中,无论是高加索人群还是亚洲人群,COMTVal158Met基因多态性与精神分裂症发病风险无统计学依据(P>0.05)。结论:COMTVal158Met基因多态性与精神分裂症患病风险可能无相关性。 Background: To evaluate the correlation of COMT Val158Met gene with susceptibility to schizophrenia. Methods: A meta-analysis was performed by searching the published literatures in PubMed, CNKI, CBM, EMBASE, MEDLINE and Wanfang databases. Overall and subgroup analyses were performed. Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the associations between COMT Val158Met polymorphisms and schizophrenia risk. Statistical analysis was performed with Review Manager 5.1. Results: Seventeen studies addressing COMT Val158Met polymorphisms were analyzed among a total of 4 935 schizophrenic cases and 4 282 controls. There was no evidence that the COMT Val158Met polymorphism was associated with an increased schizophrenia risk (P〉0.05) in over all populations (heterozygote comparison, P= 0.07, I2=1%; recessive model comparison, P=0.11, I2=0%). In subgroup analysis based on ethnic groups, no associations was found in Caucasus and Asians (P〉0.05). Conclusion: It is likely that the COMT Val158Met gene polymorphism does not confer susceptibility to schizophrenia.
作者 徐周洋 刘欣
出处 《神经损伤与功能重建》 2014年第4期309-313,共5页 Neural Injury and Functional Reconstruction
关键词 基因多态性 精神分裂症 META分析 COMT Va1158Met,, gene polymorphism Schizophrenia Meta-analysis
  • 相关文献

参考文献28

  • 1Sugarman PA,Craufurd D.Schizophrenia in the Afro-Caribbean community[J].Br J Psychiatry,1994,164:474-480.
  • 2Kraepelin E.Dementia praecox and paraphrenia[M].New York:International Universities press lnc,1950.
  • 3Jurewicz I,Owen RJ,O Donovan MC,et al.searching for susceptibility genes in schizophrenia[J].Eur Neuropsychopharmacol,2001,11:B395-398.
  • 4McGrath J,Saha S,Chant D,et al.Schizophrenia:a concise overview of incidence,prevalence,and mortality[J].Epidemiol Rev,2008,30:67-76.
  • 5Andreasen NC,Arndt S,Alliger R,et al.Symptoms of schizophrenia.Methods,meanings,and mechanisms[J].Arch Gen Psychiatry,1995,52:341-351.
  • 6Hattori M,Nanko S,Dai XY,et al.Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia[J].Biochem Biophys Res Commun,1994,202:757-763.
  • 7Borglum AD,Hampson M,Kjeldsen TE,et al.Dopa decarboxylase genotypes may influence age at onset of schizophrenia[J].Mol Psychiatry,2001,6:712-717.
  • 8Milunsky J,Huang XL,Wyandt HE,et al.Schizophrenia susceptibility gene locus at Xp22.3[J].Clin Genet,1999,55:455-460.
  • 9Han DH,Park DB,Na C,et al.Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltrans ferase genes[J].Psychiatry Res,2004,129:29-37.
  • 10Tovilla-Zarate C,Medellin BC,Fresan A,et al.No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population[J].Mol Biol Rep,2013,40:2053-2058.

二级参考文献23

  • 1姜红燕,许秀峰.精神分裂症与儿茶酚氧位甲基转移酶基因多态性[J].国外医学(遗传学分册),2005,28(5):309-312. 被引量:6
  • 2沈渔邨.精神病学(第3版)[M].北京:人民卫生出版社,1995.917.
  • 3沈渔邮.精神病学[M].北京:人民卫生出版社,1998.586-600.
  • 4Lewis DA,Lieberman JA. Catching up on schizophrenia: natural history and neurobiology[J]. Neuron,2000,28(2):325- 334.
  • 5Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia[J]. Arch Gen Psychiatry,1982,39(4):486-487.
  • 6Lachman HM, Papolos DF, Saito T, et al. Human catechol-O- methyl-transferas pharmaeogentics: description of a functional polymorphism and its potential application to neuropsychiatric disorders[J]. Pharmacogenetics, 1996,6(3) : 243-250.
  • 7Simpson GM. The treatment of tardive dyskinesia and dystonia[J]. Clin Psychiatry,2000,16(4) :39- 44.
  • 8Kane JM, Smity JM. Tardive dyskinesia: prevalence and risk factor, 1959 to 1979[J]. Arch Gen Psychiatry, 1982,39(4) : 473- 481.
  • 9Danids JK, Williams NM, Williams J, et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyhransferase activity. Am J psychiatry, 1996, 153:268 -270.
  • 10Floderus Y, Ross SB, Wetterberg L. Erythrocyte catechol-O-methyltransferase activity in a Swedish population. Clin Genet, 1981, 19:389-392.

共引文献23

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部